RES003, a resveratrol derivative with an IC50 of 0.87 μM, can improve chronic stress-induced depression-like behaviors and other psychiatric disorders by inhibiting PDE4 and upregulating the p-CREB/BDNF signaling pathway [76]. This evidence concerns the gene CREB1 and depressive symptom measurement.